UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - TRANSLATE BIO INC ownership

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$1,047,319,000
+87.3%
38,029
+12.1%
0.00%
Q1 2021$559,176,000
-32.6%
33,910
-24.6%
0.00%
Q4 2020$829,350,000
+61.6%
45,000
+19.4%
0.00%
Q3 2020$513,097,000
+53.1%
37,700
+101.6%
0.00%
Q2 2020$335,104,000
-19.1%
18,700
-54.8%
0.00%
Q3 2018$414,000,000
-20.9%
41,4000.0%0.00%
Q2 2018$523,710,00041,4000.00%
Other shareholders
TRANSLATE BIO INC shareholders Q2 2024
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 1,872,115$30,871,0005.70%
FRAZIER MANAGEMENT LLC 2,182,789$35,994,0002.89%
Baupost Group 18,044,239$295,810,0002.36%
RTW INVESTMENTS, LP 4,382,199$72,262,0001.13%
DAFNA Capital Management LLC 225,393$3,717,0000.88%
Camber Capital Management LP 1,150,000$18,964,0000.65%
EcoR1 Capital, LLC 596,900$9,843,0000.44%
Alpha Paradigm Partners, LLC 50,393$831,000,0000.32%
Birchview Capital, LP 30,000$495,0000.29%
Artal Group S.A. 1,000,000$16,490,0000.29%
View complete list of TRANSLATE BIO INC shareholders